Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Organon BioSciences

1923 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
2 INVESTMENTS
Description

Manufacturer of pharmaceutical products. The company develops, manufactures and markets products targeting selected therapeutic areas in human pharmaceuticals and covering a wide range of species in animal health. It offers its products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care and neuroscience, immunology, animal health and oncology.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Molenstraat 110
  • 5342 CC Oss
  • Netherlands

Organon BioSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Organon BioSciences‘s full profile, request access.

Request full access to PitchBook

Organon BioSciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 & 0000000 22-May-2013 000000000 00000 00 Medical Supplies
Kadmus Pharmaceuticals (FAAH Inhibitor Technology OSS) 26-Jun-2007 Corporate Asset Purchase Pharmaceuticals 00000000 0000000000
To view this company’s complete investment and acquisition history, request access »

Organon BioSciences Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Organon BioSciences‘s full profile, request access.

Request full access to PitchBook

Organon BioSciences Executive Team (1)

Name Title Board
Seat
Contact
Info
Antonius Wilderbeek President & Chief Executive Officer